$VSBC

VITASPRING BIOMEDICAL CO. LTD.

CIK:0001697884|SEC Filings

STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	Jul. 31, 2026	Jul. 31, 2025	Jul. 31, 2026	Jul. 31, 2025
STATEMENTS OF OPERATIONS (Unaudited)
Revenues	$ 0	$ 0	$ 0	$ 0
Operating expenses
Professional fees	98,174	35,200	110,374	38,700
Payroll expenses	57,813	57,813	115,625	115,625
General and administrative expenses	5,830	6,054	11,662	13,889
Total operating expenses	161,817	99,067	237,661	168,214
Loss from operations	(161,817)	(99,067)	(237,661)	(168,214)
Other income
Other income	6,000	0	6,000	0
Total other income	6,000	0	6,000	0
Net loss before provision for income taxes	(155,817)	(99,067)	(231,661)	(168,214)
Provision for income taxes	0	(11,778)	0	(23,172)
Net loss	$ (155,817)	$ (110,845)	$ (231,661)	$ (191,386)
Net loss per share: Basic and diluted	$ (0.00)	$ (0.00)	$ (0.00)	$ (0.00)
Weighted average number of shares outstanding: Basic and diluted	207,030,030	207,030,030	207,030,030	207,030,030

STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	6 Months Ended
STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	Jul. 31, 2026	Jul. 31, 2025
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (231,661)	$ (191,386)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense	4,149	4,979
Changes in assets and liabilities:
Prepaid expenses	6,988	(6,925)
Other receivable	0	(169)
Payroll liability	115,625	115,625
Accounts payable and other payables	(30,035)	(50,884)
Income tax and franchise tax expenses payable	(1,382)	22,372
Advances from related party for operating expenses	147,599	104,415
Net cash provided by (used in) operating activities	11,283	(1,973)
CASH FLOWS FROM FINANCING ACTIVITY
Advances from related party	0	2,500
Net cash provided by financing activity	0	2,500
Net change in cash	11,283	527
Cash at beginning of period	2,084	272
Cash at end of period	13,367	799
Supplemental cash flow disclosures:
Income taxes paid	0	0
Interest expense paid	0	0
Non-cash investing and financing activities
Reclassification of accounts payable - related party to loan payable - related party	$ 2,411,000	$ 0

BALANCE SHEETS - USD ($)	Jul. 31, 2026	Jan. 31, 2026
CURRENT ASSETS
Cash	$ 13,367	$ 2,084
Prepaid expenses	1,455	8,443
Total current assets	14,822	10,527
LONG-TERM ASSET
Equipment and vehicle, net	0	4,149
Total long-term asset	0	4,149
Total assets	14,822	14,676
CURRENT LIABILITIES
Accounts payable - related party	0	2,411,000
Accounts payable and other payables	139,420	169,455
Payroll liability	598,197	482,572
Income tax payable	342,852	344,234
Advances from related party	1,185,582	1,037,983
Total current liabilities	2,266,051	4,445,244
LONG-TERM LIABILITY
Loan payable - related party	2,411,000	0
Total long-term liability	2,411,000	0
Total liabilities	4,677,051	4,445,244
COMMITMENTS AND CONTINGENCIES	0	0
STOCKHOLDERS' DEFICIT
Common stock, $0.0001 par value; 500,000,000 shares authorized; 207,030,030 shares issued and outstanding as of July 31, 2026 and January 31, 2026.	20,703	20,703
Additional paid-in capital	1,245,600	1,245,600
Accumulated deficit	(5,928,532)	(5,696,871)
Total stockholders' deficit	(4,662,229)	(4,430,568)
Total liabilities and stockholders' deficit	$ 14,822	$ 14,676